Search: onr:"swepub:oai:lup.lub.lu.se:c6e4f055-a5f8-410c-a688-d2e775552bc7" >
Enhanced cGMP Inter...
-
Rasmussen, MichelLund University,Lunds universitet,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Department of Clinical Sciences, Lund,Faculty of Medicine
(author)
Enhanced cGMP Interactor Rap Guanine Exchange Factor 4 (EPAC2) Expression and Activity in Degenerating Photoreceptors: : A Neuroprotective Response?
- Article/chapterEnglish2022
Publisher, publication year, extent ...
-
2022-04-21
-
MDPI AG,2022
-
electronicrdacarrier
Numbers
-
LIBRIS-ID:oai:lup.lub.lu.se:c6e4f055-a5f8-410c-a688-d2e775552bc7
-
https://lup.lub.lu.se/record/c6e4f055-a5f8-410c-a688-d2e775552bc7URI
-
https://doi.org/10.3390/ijms23094619DOI
Supplementary language notes
-
Language:English
-
Summary in:English
Part of subdatabase
Classification
-
Subject category:art swepub-publicationtype
-
Subject category:ref swepub-contenttype
Notes
-
The disease retinitis pigmentosa (RP) leads to photoreceptor degeneration by a yet undefined mechanism(s). In several RP mouse models (i.e., rd mice), a high cyclic GMP (cGMP) level within photoreceptors is detected, suggesting that cGMP plays a role in degeneration. The rap guanine exchange factor 4 (EPAC2) is activated by cyclic AMP (cAMP) and is an accepted cGMP-interacting protein. It is unclear whether and how cGMP interacts with EPAC2 in degenerating photoreceptors; we therefore investigated EPAC2 expression and interactions with cGMP and cAMP in retinas of the rd1 and rd10 models for retinal degeneration. EPAC2 expression in the photoreceptor layer increased significantly during rd1 and rd10 degeneration, and an increase in EPAC2 interactions with cGMP but not cAMP in the rd1 was also seen via a proximity ligation assay on histological sections. Retinal explant cultures revealed that pharmacological inhibition of the EPAC2 activity reduced the photoreceptor layer thickness in the rd10 retina, suggesting that EPAC2 inhibition promotes degeneration. Taken together, our results support the hypothesis that high degeneration-related cGMP leads to increased EPAC2 and cGMP interactions, inhibiting EPAC2. By inference, EPAC2 could have neuroprotective capacities that may be exploited in the future.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Zhou, JiamingLund University,Lunds universitet,Oftalmologi, Lund,Sektion IV,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Ophthalmology, Lund,Section IV,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)ji6872zh
(author)
-
Schwede, FrankBIOLOG Life Science Institute
(author)
-
Ekström, PerLund University,Lunds universitet,Institutionen för kliniska vetenskaper, Lund,Medicinska fakulteten,Department of Clinical Sciences, Lund,Faculty of Medicine(Swepub:lu)zoof-pek
(author)
-
Institutionen för kliniska vetenskaper, LundMedicinska fakulteten
(creator_code:org_t)
Related titles
-
In:International Journal of Molecular Sciences: MDPI AG23:91422-0067
Internet link
Find in a library
To the university's database